Level Chart

Basic Info

Becton Dickinson and Co (BDX) - Life Sciences Revenue is at a current level of 766.00M, up from 0.000 last quarter and down from 836.00M one year ago. This is a change of N/A from last quarter and -8.37% from one year ago.

Region United States
Source Fiscal.ai

Data provided via Fiscal.ai

Stats

Last Value 766.00M
Latest Period Dec 2025
Last Updated Mar 23 2026, 14:08 EDT
Next Release Apr 15 2026, 08:30 EDT (E)
Average Growth Rate -400.0%
Value from Last Quarter 0.00
Change from Last Quarter N/A
Value from 1 Year Ago 836.00M
Change from 1 Year Ago -8.37%
Frequency Quarterly
Unit USD
Adjustment N/A
Download Source File

Historical Data

View and export this data back to 2019. Upgrade now.
Date Value
December 31, 2025 766.00M
September 30, 2025 0.00
June 30, 2025 0.00
March 31, 2025 0.00
December 31, 2024 836.00M
September 30, 2024 0.00
June 30, 2024 0.00
March 31, 2024 0.00
December 31, 2023 0.00
September 30, 2023 0.00
June 30, 2023 0.00
March 31, 2023 0.00
December 31, 2022 0.00
Date Value
September 30, 2022 0.00
June 30, 2022 0.00
March 31, 2022 0.00
December 31, 2021 0.00
September 30, 2021 0.00
June 30, 2021 0.00
March 31, 2021 0.00
December 31, 2020 0.00
September 30, 2020 0.00
June 30, 2020 0.00
March 31, 2020 0.00
December 31, 2019 0.00

Basic Info

Becton Dickinson and Co (BDX) - Life Sciences Revenue is at a current level of 766.00M, up from 0.000 last quarter and down from 836.00M one year ago. This is a change of N/A from last quarter and -8.37% from one year ago.

Region United States
Source Fiscal.ai

Data provided via Fiscal.ai

Stats

Last Value 766.00M
Latest Period Dec 2025
Last Updated Mar 23 2026, 14:08 EDT
Next Release Apr 15 2026, 08:30 EDT (E)
Average Growth Rate -400.0%
Value from Last Quarter 0.00
Change from Last Quarter N/A
Value from 1 Year Ago 836.00M
Change from 1 Year Ago -8.37%
Frequency Quarterly
Unit USD
Adjustment N/A
Download Source File

Related Securities

Symbol Name Change %
BDX Becton, Dickinson & Co. -0.57%